Literature DB >> 9372357

Increased cutaneous toxicity to ionizing radiation in HIV-positive patients. Military Medical Consortium for the Advancement of Retroviral Research (MMCARR).

K J Smith1, H G Skelton, S Tuur, J Yeager, C Decker, K F Wagner.   

Abstract

BACKGROUND: There are reports of increased reactions in HIV-1+ patients to ultraviolet light sometimes in association with medication. In addition, there are also reports of increased morbidity associated with radiation therapy in HIV-1+ patients.
METHODS: Three HIV-1+ patients developed cutaneous toxic reactions to radiation therapy; two with Kaposi's sarcoma (KS) and one with non-Hodgkin's lymphoma.
CONCLUSIONS: Although the mechanisms which resulted in these reactions are not clear, they may be related to depletion of endogenous scavengers and may be accentuated by the pattern of immune dysregulation present in HIV-1 disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9372357     DOI: 10.1046/j.1365-4362.1997.00255.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  3 in total

Review 1.  New insights into HIV-1-primary skin disorders.

Authors:  Filiberto Cedeno-Laurent; Minerva Gómez-Flores; Nora Mendez; Jesús Ancer-Rodríguez; Joseph L Bryant; Anthony A Gaspari; Jose R Trujillo
Journal:  J Int AIDS Soc       Date:  2011-01-24       Impact factor: 5.396

2.  Sequential development of psoriasis, alopecia universalis, and vitiligo vulgaris in a human immunodeficiency virus seropositive patient: A unique case report.

Authors:  Sudarshan P Gaurkar; Kirti S Parmar; Bela J Shah
Journal:  Indian J Sex Transm Dis AIDS       Date:  2014 Jul-Dec

3.  The HIV-derived protein Vpr52-96 has anti-glioma activity in vitro and in vivo.

Authors:  Jens Kübler; Stefanie Kirschner; Linda Hartmann; Grit Welzel; Maren Engelhardt; Carsten Herskind; Marlon R Veldwijk; Christian Schultz; Manuela Felix; Gerhard Glatting; Patrick Maier; Frederik Wenz; Marc A Brockmann; Frank A Giordano
Journal:  Oncotarget       Date:  2016-07-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.